Description: Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.
Home Page: www.bd.com
BDXB Technical Analysis
1 Becton Drive
Franklin Lakes,
NJ
07417-1880
United States
Phone:
201 847 6800
Officers
| Name | Title |
|---|---|
| Mr. Thomas E. Polen Jr. | Pres, CEO & Chairman |
| Mr. Christopher DelOrefice | Exec. VP & CFO |
| Mr. Samrat S. Khichi Esq. | Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel |
| Mr. Thomas J. Spoerel | Sr. VP, Controller & Chief Accounting Officer |
| Ms. Elizabeth McCombs | Exec. VP & Chief Technology Officer |
| Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. | Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board |
| Ms. Denise Fleming | Exec. VP of Technology & Global Services and Chief Information Officer |
| Ms. Francesca M. DeMartino | Sr. VP & Head of Investor Relations |
| Michelle Quinn | Sr. VP and Chief Ethics & Compliance Officer |
| Troy Kirkpatrick | VP of PR |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 7.9018 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2020-05-21 |
| Fiscal Year End: | September |
| Full Time Employees: | 77000 |